Literature DB >> 567064

Body water and weight in patients with premenstrual tension.

B Andersch, L Hahn, M Andersson, B Isaksson.   

Abstract

The total body water, total body potassium and weight were studied during the follicular and luteal phases of the cycle in 20 patients with severe premenstrual tension and 20 controls without symptoms. The effects of a diuretic (bumetanide) and bromocriptine were also studied in the patients with premenstrual tension. The mean body water in the premenstrual tension group did not differ significantly from that in the controls neither did the mean body potassium levels. However, during the late luteal phase the water/potassium ratio in liters per mol of potassium was significantly higher in the patients with premenstrual tension than in the controls. In the women with premenstrual tension the body water values varied more widely between the luteal phase and follicular phase than in the controls. The mean body water and weight in the premenstrual tension group were similar in the late luteal and early follicular phases. Treatment with bumetanide or bromocriptine had no effect on the parameters studied.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567064

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  6 in total

Review 1.  Treating the premenstrual syndrome.

Authors:  D Gath; S Iles
Journal:  BMJ       Date:  1988-07-23

2.  Premenstrual tension syndrome.

Authors: 
Journal:  Br Med J       Date:  1979-01-27

Review 3.  Premenstrual syndrome. Identification and management.

Authors:  S K Severino; M L Moline
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 4.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

5.  Premenstrual syndrome.

Authors:  Kimberly Ann Yonkers; P M Shaughn O'Brien; Elias Eriksson
Journal:  Lancet       Date:  2008-04-05       Impact factor: 79.321

Review 6.  Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  A Ward; R C Heel
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.